# Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.

> **NCT05369039** · PHASE2 · UNKNOWN · sponsor: **Menoufia University** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** Roflumilust
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT05369039
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369039, "Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05369039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*